Health and Medical Guide to Eyes and Vision Melanoma Health information topics about Melanoma: Clinical Trials 1. ClinicalTrials.gov: Eye Neoplasms National Institutes of Health http://clinicaltrials.gov/ct/gui/action/FindCondition?ui=D005134&recruiting... 2. ClinicalTrials.gov: Melanoma National Institutes of Health http://clinicaltrials.gov/ct/gui/action/FindCondition?ui=D008545&recruiting... Coping 1. Coping with Melanoma Skin Cancer Foundation http://www.skincancer.org/melanoma/coping.html Diagnosis/Symptoms 1. Biopsy: What to Expect American Academy of Dermatology http://www.skincarephysicians.com/skincancernet/biopsy.html 2. Staging: The First Step in Treating Skin Cancer American Academy of Dermatology http://www.skincarephysicians.com/skincancernet/staging.html 3. Skin Examinations American Academy of Dermatology http://www.skincarephysicians.com/skincancernet/skin_examinations.html 4. Detection of Suspicious Lesion Improves with Famil American Academy of Dermatology http://www.skincarephysicians.com/skincancernet/detection.html Dictionaries/Glossaries 1. Cancer.gov Dictionary National Cancer Institute http://www.cancer.gov/dictionary/ 2. Glossary American Academy of Dermatology http://www.skincarephysicians.com/skincancernet/glossary.html Directories 1. Find a Dermatologist American Academy of Dermatology http://www.aad.org/public/OtherResources/searchderm.htm Genetics 1. Genes and Disease: Malignant Melanoma National Center for Biotechnology Information http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowSection&rid=gnd... Health Check Tools 1. Melanoma Cancer Questionnaire Harvard Center for Cancer Prevention http://www.yourdiseaserisk.harvard.edu/hccpquiz.pl?func=d_start&cancer_list... National Institutes of Health 1. Melanoma (PDQ): Treatment National Cancer Institute http://www.cancer.gov/cancerinfo/pdq/treatment/melanoma/patient/ 2. What You Need to Know about Moles and Dysplastic N National Cancer Institute http://www.cancer.gov/cancerinfo/wyntk/moles-and-dysplastic-nevi 3. What You Need to Know about Melanoma National Cancer Institute http://www.cancer.gov/cancerinfo/wyntk/melanoma Organizations 1. American Academy of Dermatology http://www.aad.org/ 2. American Cancer Society http://www.cancer.org/ 3. National Cancer Institute http://www.cancer.gov/ 4. Skin Cancer Foundation http://www.skincancer.org/ Overviews 1. Melanoma Mayo Foundation for Medical Education and Research http://www.mayoclinic.com/invoke.cfm?id=DS00439 2. Melanoma: A Kind of Skin Cancer American Academy of Family Physicians http://familydoctor.org/666.xml Pictures/Diagrams 1. Melanoma: What It Looks Like American Academy of Dermatology http://www.skincarephysicians.com/skincancernet/melanoma.html Prevention/Screening 1. Can Melanoma Be Prevented? American Cancer Society http://www.cancer.org/docroot/cri/content/cri_2_4_2x_can_melanoma_be_preven... 2. Who Is Most at Risk for Melanoma? American Academy of Dermatology http://www.skincarephysicians.com/skincancernet/who_is_most.html Related Issues 1. When to See a Dermatologist American Academy of Dermatology http://www.skincarephysicians.com/skincancernet/whentosee.html 2. Atypical Moles American Academy of Dermatology http://www.skincarephysicians.com/skincancernet/atypical_moles.html Research 1. What's New in Melanoma Skin Cancer Research? American Cancer Society http://www.cancer.org/docroot/CRI/content/CRI_2_2_7X_Whats_new_in_melanoma_... 2. Sunscreen Use and Melanoma American College of Physicians http://www.annals.org/cgi/content/full/139/12/I-16 3. Researchers Shut Off Immune Cell Inhibition, Causi National Cancer Institute http://www.cancer.gov/newscenter/pressreleases/CTLA4 4. NCI Researchers Confirm the Effectiveness of Immun National Cancer Institute http://www.nih.gov/news/pr/mar2005/nci-31.htm 5. Low-Dose Interferon Doesn't Help High-Risk Me American Cancer Society http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Low-Dose_Interferon_Does... 6. Do We Know What Causes Melanoma? American Cancer Society http://www.cancer.org/docroot/cri/content/cri_2_4_2x_do_we_know_what_causes... Specific Conditions 1. About Choroidal Melanoma Wilmer Eye Institute http://www.jhu.edu/wctb/coms/booklet/book2.htm 2. Hidden Melanomas American Academy of Dermatology http://www.skincarephysicians.com/skincancernet/hidden_melanomas.html 3. Intraocular (Eye) Melanoma (PDQ): Treatment National Cancer Institute http://www.cancer.gov/cancerinfo/pdq/treatment/intraocularmelanoma/patient/... 4. Melanoma in African Americans American Academy of Dermatology http://www.aad.org/public/News/NewsReleases/Melanoma_AfricanAmericans.htm 5. Vaginal Melanoma Mayo Foundation for Medical Education and Research http://www.mayoclinic.com/invoke.cfm?id=AN00403 Statistics 1. SEER Cancer Statistics Review 1975-2001: Melanoma National Cancer Institute http://seer.cancer.gov/csr/1975_2001/results_merged/sect_16_melanoma.pdf 2. What Are the Key Statistics About Melanoma? American Cancer Society http://www.cancer.org/docroot/cri/content/cri_2_4_1x_what_are_the_key_stati... Treatment 1. Treating Melanoma American Academy of Dermatology http://www.skincarephysicians.com/skincancernet/treating_melanoma.html 2. Melanoma: How It Returns, Where It Spreads American Academy of Dermatology http://www.skincarephysicians.com/skincancernet/melanoma_returns.html   Eye Health / Blindness News From Medical News Today Latest Health News and Medical News posted throughout the day, every day. Alcon Launches AcrySof(R) IQ ReSTOR(R) Toric Intraocular Lens Outside The Uni... 5 Sep 2010 at 2:00am Alcon, Inc. (NYSE: ACL), the world's leader in eye care and cataract surgery, announced its launch of the AcrySof® IQ ReSTOR® Multifocal Toric intraocular lens (IOL) outside the United States during the 2010 European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting in Paris, France... Starting The School Year Right 4 Sep 2010 at 4:00am As many children head back to school this fall, are they truly prepared for what lies ahead? With a few simple medical exams; Maine's school-age children will be armed with the tools they need to have a healthier school year... Drug Discovery Tools To Fight Cancer, Blindness To Be Discussed At UB Symposium 3 Sep 2010 at 7:00am Twenty-first-century pharmaceutical breakthroughs require 21st-century drug discovery tools, such as computational or in silico molecular design and high-throughput screening of effective, new compounds. That's the theme of a University at Buffalo symposium to be held Sept... 'Back-To-School' How To Prevent Sports Related Eye Injuries 3 Sep 2010 at 6:00am It's back to school time! Kids are feeling excited and maybe a little nervous. New teachers, new friends and new sports seasons. Parents are scrambling to buy back-to-school clothes and equip their children with all the sports gear they need, like helmets, pads, braces and mouth guards... Carl Zeiss Meditec Is Shaping The Future Of Ophthalmology: Creating What's To... 3 Sep 2010 at 5:00am Carl Zeiss Meditec is once again presenting its expanded offer of solutions for cataract, refractive and retina applications. Under the theme - Creating what's to come - the company is demonstrating how it would like to shape the future of ophthalmology with its products and solutions... OptiMedica's Laser Cataract Surgery System To Be Featured In Three Clinical P... 3 Sep 2010 at 4:00am Global ophthalmic device company OptiMedica Corp. has announced that clinical results for its laser cataract surgical system will be the subject of three presentations at the European Society of Cataract and Refractive Surgeons annual meeting in Paris, September 4 - 8... Dr. Tom Tooma Purchases Interest In All 12 Southern California TLC Laser Eye ... 2 Sep 2010 at 8:00am All 12 TLC Laser Eye Centers in Southern California are changing their names to NVISION Laser Eye Centers. The name change accompanies the sale of TLC Vision's interest in the 12 centers to Medical Director Dr. Tom Tooma to become a separate LASIK brand. The new brand will operate as NVISION Laser Eye Centers and will have the same 12 Southern California locations, same surgeons and staff... Bausch + Lomb Releases Single-Use Vitreoretinal Asymmetric Peeling Forceps 2 Sep 2010 at 6:00am Bausch + Lomb Storz® Ophthalmic Instruments announces the U.S. release of a new, single-use, asymmetric peeling forceps for vitreoretinal surgery. The forceps are available in 23- and 25-gauge options for facilities seeking the safety, consistency and convenience a single-use instrument offers... New Data Will Help Predict Vision Loss In Glaucoma 2 Sep 2010 at 6:00am Eye M.D.s are intent on finding better ways to diagnose and treat glaucoma, a complex, potentially blinding disease. September's Ophthalmology journal includes new data from the Rotterdam Study that will help doctors better predict visual field loss (VFL) in glaucoma patients. Johannes R... Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results 2 Sep 2010 at 4:00am A recent study conducted by oculoplastic surgeon Charles Soparkar, M.D., Ph.D. (The Methodist Hospital, Houston, TX) utilizing a patent-pending formulation of zinc and phytase (trademarked as ZYTAZE™), demonstrated that increasing zinc levels by oral administration for 4 days prior to a planned injection of botulinum toxin improved efficacy and/or duration in 41 of 44 patients tested (93%)... ReVision's Fenretinide (RT-101) Reduced Incidence Of Choroidal Neovasculariza... 2 Sep 2010 at 4:00am ReVision Therapeutics Inc. announced that data from a Phase 2b trial show that fenretinide (RT-101) reduced the incidence of choroidal neovascularization (CNV, wet age related macular degeneration) by about 50 percent in patients with geographic atrophy (GA), the most advanced form of dry age related macular degeneration (AMD). The data, presented Monday by Alexander M. Eaton, M.D... Microplasmin Meets Primary Endpoint In Second Phase III Trial In VMA, Confirm... 2 Sep 2010 at 4:00am ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer announces that its second Phase III trial evaluating microplasmin for the non-surgical treatment of vitreomacular adhesion (VMA) has met its primary endpoint... pSivida Announces Iluvien(R) Receives FDA Priority Review For Treatment Of Di... 2 Sep 2010 at 3:00am pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, announced that its licensee, Alimera Sciences (NASDAQ:ALIM) has been notified that the U.S... Allergan Receives FDA Approval For LUMIGAN(R) 0.01% As First-Line Therapy Ind... 2 Sep 2010 at 2:00am Allergan, Inc. (NYSE:AGN) announced the United States Food and Drug Administration (FDA) has approved LUMIGAN® (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. LUMIGAN® 0... Improving Ocular Disease Screening By LED Illumination Of The Eye 1 Sep 2010 at 6:00am A new imaging system using six different wavelengths to illuminate the interior of the eyeball (ocular fundus) may pave the way for doctors to easily screen patients for common diseases of the eye, such as age-related macular degeneration and diabetic retinopathy. The system is described in the journal Review of Scientific Instruments, which is published by the American Institute of Physics...     HealthBusinessBuilder.com Build your Health Business Fast!